Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.349ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.349NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.314ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.314ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.314ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.314NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.132ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.132ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.132ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.132NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.38ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.38ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.38ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.38NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.42ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.42ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.42ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.42NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
K.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.62ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.62ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.62NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GA.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GA.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GA.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.23ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.23ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.23NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.2.3.13ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.2.3.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.3.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.13NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.160ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.160ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JV.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JV.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JV.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JV.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XCYORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XCYENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCYENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCYNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.16ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.16NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used